MedTrace Logo

Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use

NCT01938534 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 440

Last updated 2014-01-01

No results posted yet for this study

Summary

Prospective study : Helicobacter pylori eradication therapy in accordance with past antibiotics use.

Conditions

  • Helicobacter Eradication

Interventions

DRUG

Helicobacter pylori eradication

Sponsors & Collaborators

  • Ajou University School of Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2014-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01938534 on ClinicalTrials.gov